Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer

We report unexpectedly high efficacy of temsirolimus as third-line treatment in a patient with metastatic chromophobe renal cell carcinoma. After failure of two sequentially administered tyrosine kinase inhibitors, treatment with temsirolimus resulted in a prolonged partial remission of 14 months, a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zardavas, Dimitrios, Meisel, Alexander, Samaras, Panagiotis, Knuth, Alexander, Renner, Christoph, Pestalozzi, Bernhard C., Stenner-Liewen, Frank
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2011
Gaiak:
Published: January 2011
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082484/
https://ncbi.nlm.nih.gov/pubmed/21526001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000323804
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak